Plasma Hepcidin as a Prognostic Biomarker in Obese and Nonobese Patients With Early Breast Cancer: A Pooled Analysis of Two Prospective Cohort Studies

By afschroeder • April 4, 2026

Cescon E, Goodwin P, Bobrie A, Thezenas S, Ganz T, Nemeth E, Lohmann A, Ennis M, Jacot W, Jerzak KJ. Plasma Hepcidin as a Prognostic Biomarker in Obese and Nonobese Patients With Early Breast Cancer: A Pooled Analysis of Two Prospective Cohort Studies. Clin Breast Cancer. 2026 Apr 2;26(5):29-35. doi: 10.1016/j.clbc.2026.03.004. Epub ahead of print. PMID: 41932199.

Tags: biomarkers, breast neoplasms, Inflammation, iron metabolism, Obesity, Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

Fraudulent and Imposter Participants in Qualitative Research: Experiences from Two Multi-Site Studies

Harden D, Rodriguez N, Roybal K, Coffin T, Johnson G, Le Beaux K, Connolly M, Rountree J, Ukaegbu C, Revette AC, Nava-Coulter B, Caruso A,[...]

Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer

Sayar E, Richards HM, Gulati R, Patel RA, Hanratty B, Lee HJ, Coleman I, Mustafi P, Ding CC, Chen WS, Quigley D, Setty M, Lang[...]

Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies

Maron SB, Xu RH, Wainberg ZA, Rha SY, Zhang Y, Pietrantonio F, Oliveira SCS, Li Y, Chen MH, Korphaisarn K, Elimova E, Calderon CA, Herpe[...]